BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10358140)

  • 1. Human anti-porcine T cell response: blocking with anti-class I antibody leads to hyporesponsiveness and a switch in cytokine production.
    DerSimonian H; Pan L; Yatko C; Rodrigue-Way A; Johnson E; Edge AS
    J Immunol; 1999 Jun; 162(12):6993-7001. PubMed ID: 10358140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
    Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
    J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xenogeneic cells and superantigen induce human T-cell activation in the absence of T-cell recognition of xenoantigen.
    Diaz LA; Pai R; Endres J; Anthony P; Duzyj C; Bishu S; Morita Y; Fox DA
    J Lab Clin Med; 2003 Sep; 142(3):149-57. PubMed ID: 14532902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human anti-porcine xenogeneic T cell response. Evidence for allelic specificity of mixed leukocyte reaction and for both direct and indirect pathways of recognition.
    Yamada K; Sachs DH; DerSimonian H
    J Immunol; 1995 Dec; 155(11):5249-56. PubMed ID: 7594537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo IL-4 responses to anti-IgD antibody are MHC class II dependent and beta 2-microglobulin independent and develop normally in the absence of IL-4 priming of T cells.
    Morris SC; Coffman RL; Finkelman FD
    J Immunol; 1998 Apr; 160(7):3299-304. PubMed ID: 9531287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human antiporcine cellular repertoire. In vitro studies of acquired and innate cellular responsiveness.
    Kirk AD; Li RA; Kinch MS; Abernethy KA; Doyle C; Bollinger RR
    Transplantation; 1993 Apr; 55(4):924-31. PubMed ID: 8475569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
    Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
    Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8+CD122+ regulatory T cells recognize activated T cells via conventional MHC class I-alphabetaTCR interaction and become IL-10-producing active regulatory cells.
    Rifa'i M; Shi Z; Zhang SY; Lee YH; Shiku H; Isobe K; Suzuki H
    Int Immunol; 2008 Jul; 20(7):937-47. PubMed ID: 18495626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human T-cell-porcine endothelial cell interactions induce human Th1 cytokines and porcine activation markers.
    Coleman TS; Pittman HK; Purser SM; Haisch CE; Verbanac KM
    J Surg Res; 2001 May; 97(2):184-91. PubMed ID: 11341797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
    Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TCR-independent cytokine stimulation induces non-MHC-restricted T cell activity and is negatively regulated by HLA class I.
    von Geldern M; Simm B; Braun M; Weiss EH; Schendel DJ; Falk CS
    Eur J Immunol; 2006 Sep; 36(9):2347-58. PubMed ID: 16909431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early regulation of CD8 T cell alloreactivity by CD4+CD25- T cells in recipients of anti-CD154 antibody and allogeneic BMT is followed by rapid peripheral deletion of donor-reactive CD8+ T cells, precluding a role for sustained regulation.
    Fehr T; Takeuchi Y; Kurtz J; Wekerle T; Sykes M
    Eur J Immunol; 2005 Sep; 35(9):2679-90. PubMed ID: 16082727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MICA antigens stimulate T cell proliferation and cell-mediated cytotoxicity.
    Zhang Y; Stastny P
    Hum Immunol; 2006 Mar; 67(3):215-22. PubMed ID: 16698445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major histocompatibility complex class II antigens are required for both cytokine production and proliferation induced by mercuric chloride in vitro.
    Hu H; Möller G; Abedi-Valugerdi M
    J Autoimmun; 1997 Oct; 10(5):441-6. PubMed ID: 9376071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porcine T lymphocytes and NK cells--an update.
    Gerner W; Käser T; Saalmüller A
    Dev Comp Immunol; 2009 Mar; 33(3):310-20. PubMed ID: 18601948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional oral tolerance in transgenic 2C mice.
    Margenthaler JA; Flye MW
    Surgery; 2005 Aug; 138(2):141-9. PubMed ID: 16153420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ICOS-ligand, expressed on human endothelial cells, costimulates Th1 and Th2 cytokine secretion by memory CD4+ T cells.
    Khayyamian S; Hutloff A; Büchner K; Gräfe M; Henn V; Kroczek RA; Mages HW
    Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6198-203. PubMed ID: 11983910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
    Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
    J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of CD25-positive T cells during syngeneic pregnancy: production of stimulatory class II MHC molecules.
    Kyvelidou C; Chatzi K; Semitekolou M; Papathanassiou X; Vassiliadis S; Athanassakis I
    Scand J Immunol; 2009 Dec; 70(6):584-95. PubMed ID: 19906201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.